Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients

PURPOSE: To investigate the features and treatment response in Caucasian patients with polypoidal choroidal vasculopathy (PCV), initially treated with bevacizumab. METHODS: 45 eyes of 43 treatment-naïve patients with PCV were included in this retrospective study, all uniformly initially treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhalka, Fidaa El, Moisseiev, Elad, Rubowitz, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682827/
https://www.ncbi.nlm.nih.gov/pubmed/36414995
http://dx.doi.org/10.1186/s40942-022-00432-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682827/
https://www.ncbi.nlm.nih.gov/pubmed/36414995
http://dx.doi.org/10.1186/s40942-022-00432-x

Ejemplares similares